Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by Yu Yang et al., published in Annals of Internal Medicine, adding:
“Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis
DOACs were associated with an increased 1-year risk for stroke but a decreased risk for MI compared with warfarin.”
Title: Real-World Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Mitral Stenosis: A Target Trial Emulation
Authors: Yu Yang, Chin-Yao Shen, Michael Chun-Yuan Cheng, Wei Kang, Philip C. M. Au, Vincent K. C. Yan, Huei-Kai Huang, Chun Ka Wong, Kai Hang Yiu, Hung-Fat Tse, Ching-Lung Cheung, Timothy H. Rainer, Bryan P. Yan, David C. W. Siu, Ian Chi Kei Wong, Edward Chia-Cheng Lai, Esther W. Y. Chan

Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments